Story perspectives

Purdue Pharma, Sacklers Settle for $7.4 Billion in Opioid Crisis

1/24/2025

47 4

Summary

Story summary

Purdue Pharma and the Sackler family have reached a landmark $7.4 billion settlement with 15 states, acknowledging their part in the devastating opioid crisis. The Sacklers will contribute $6.5 billion, while Purdue adds $900 million. This substantial fund aims to bolster addiction treatment and prevention programs over the next 15 years, awaiting court approval.

History

Historical Context

Purdue Pharma's $7.4 billion settlement with 15 states marks a significant moment in the ongoing opioid crisis, rooted in the company's aggressive marketing of OxyContin since its 1996 release. This crisis echoes past public health emergencies, such as the tobacco epidemic, where corporate practices prioritized profit over safety, leading to widespread addiction and loss of life. The settlement aims to fund addiction treatment and prevention efforts.

1 of 2

Story summary

Purdue Pharma and the Sackler family have reached a landmark $7.4 billion settlement with 15 states, acknowledging their part in the devastating opioid crisis. The Sacklers will contribute $6.5 billion, while Purdue adds $900 million. This substantial fund aims to bolster addiction treatment and prevention programs over the next 15 years, awaiting court approval.

1 / 2